Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.

about

Phase I clinical trial of the base excision repair inhibitor methoxyamine in combination with fludarabine for patients with advanced hematologic malignancies.

Item

http://www.wikidata.org/entity/Q47140562

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Phase I clinical trial of the ...... nced hematologic malignancies.

@en

Phase I clinical trial of the ...... nced hematologic malignancies.

@nl

type

Item

label

Phase I clinical trial of the ...... nced hematologic malignancies.

@en

Phase I clinical trial of the ...... nced hematologic malignancies.

@nl

prefLabel

Phase I clinical trial of the ...... nced hematologic malignancies.

@en

Phase I clinical trial of the ...... nced hematologic malignancies.

@nl

P1476

Phase I clinical trial of the ...... nced hematologic malignancies.

@en

P2093

Afshin Dowlati

http://www.w3.org/2001/XMLSchema#string

Basem M William

http://www.w3.org/2001/XMLSchema#string

Brenda W Cooper

http://www.w3.org/2001/XMLSchema#string

John Pink

http://www.w3.org/2001/XMLSchema#string

Marcos de Lima

http://www.w3.org/2001/XMLSchema#string

Paolo F Caimi

http://www.w3.org/2001/XMLSchema#string

Paul M Barr

http://www.w3.org/2001/XMLSchema#string

Pingfu Fu

http://www.w3.org/2001/XMLSchema#string

Stanton L Gerson

http://www.w3.org/2001/XMLSchema#string

Yan Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Coordination of steps in single-nucleotide base excision repair mediated by apurinic/apyrimidinic endonuclease 1 and DNA polymerase beta

Genome maintenance mechanisms for preventing cancer

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization

Purine analog-like properties of bendamustine underlie rapid activation of DNA damage response and synergistic effects with pyrimidine analogues in lymphoid malignancies

A quantitative model of human DNA base excision repair. I. Mechanistic insights.

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients.

Fludarabine: a new agent with major activity against chronic lymphocytic leukemia.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

P304

79864-79875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.20094

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hillard M Lazarus

P577

2017-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29108368

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

5668101

http://www.w3.org/2001/XMLSchema#string